This blog is related to the various litigations related to patents w.r.t pharma industry.
Thursday, May 8, 2008
FDA Sends Novartis Warning Letter Over Trileptal Promotional Materials.
May 8, 2008-The FDA today posted on its website a warning letter sent to Novartis Pharmaceuticals regarding promotional materials for Trileptal. The letter and promotional materials can be seen as below.
No comments:
Post a Comment